SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $156,000 | -13.3% | 2,083 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $180,000 | -71.7% | 2,083 | -53.7% | 0.00% | -71.4% |
| Q3 2018 | $636,000 | +31.4% | 4,500 | +49.9% | 0.01% | +16.7% |
| Q1 2018 | $484,000 | -2.0% | 3,002 | 0.0% | 0.01% | +9.1% |
| Q4 2017 | $494,000 | -41.4% | 3,002 | -77.8% | 0.01% | -42.1% |
| Q3 2017 | $843,000 | -21.7% | 13,528 | 0.0% | 0.02% | -20.8% |
| Q2 2017 | $1,077,000 | +12.1% | 13,528 | 0.0% | 0.02% | +14.3% |
| Q1 2017 | $961,000 | +39.1% | 13,528 | 0.0% | 0.02% | +40.0% |
| Q4 2016 | $691,000 | +10.9% | 13,528 | 0.0% | 0.02% | +7.1% |
| Q3 2016 | $623,000 | – | 13,528 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |